Literature DB >> 3298252

Structure-function studies on bacteriorhodopsin. I. Expression of the bacterio-opsin gene in Escherichia coli.

R J Dunn, N R Hackett, J M McCoy, B H Chao, K Kimura, H G Khorana.   

Abstract

To express the bacterio-opsin (bop) gene in Escherichia coli, we have employed the inducible expression vectors pIN-II-A, -B, and -C (Nakamura, K., and Inouye, M. (1982) EMBO J. 1, 771-775). The vectors contain three cloning sites early in the E. coli lipoprotein gene (lpp) which is transcribed from tandem lpp and lac promoters. The bop gene was modified so as to delete the N-terminal leader sequence and then cloned into each of the three cloning sites to encode three different lipoprotein/bacterio-opsin fusions. Expression of the fusions was demonstrated both in vitro and in vivo. The fusion protein was estimated to be about 0.05% of the total cell protein. The cause for the low level of expression apparently was neither an inadequate level of mRNA nor degradation of the protein. However, expression of the fusions caused inhibition of the growth of the host to varying extents. One fusion protein was purified from E. coli membranes to homogeneity by immunoaffinity chromatography followed by preparative gel electrophoresis. The purified fusion protein generated a bacteriorhodopsin-like chromophore on treatment with defined lipid/detergent mixtures and retinal. When reconstituted into vesicles, the protein pumped protons on illumination comparably to the reconstituted native bacterio-opsin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298252

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Archaebacteria then ... Archaes now (are there really no archaeal pathogens?).

Authors:  J N Reeve
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

2.  Bacteriorhodopsin wildtype and variant aspartate-96 --> aspargine as reversible holographic media.

Authors:  N Hampp; C Bräuchle; D Oesterhelt
Journal:  Biophys J       Date:  1990-07       Impact factor: 4.033

3.  Expression of bacteriorhodopsin in Sf9 and COS-1 cells.

Authors:  J Heymann; R Jager; S Subramaniam
Journal:  J Bioenerg Biomembr       Date:  1997-02       Impact factor: 2.945

4.  Regeneration and functional incorporation of bacteriorhodopsin in membranes of fission yeast but not in E. coli.

Authors:  V Hildebrandt
Journal:  J Protein Chem       Date:  1989-06

5.  Secretory leukocyte protease inhibitor binding to mRNA and DNA as a possible cause of toxicity to Escherichia coli.

Authors:  K W Miller; R J Evans; S P Eisenberg; R C Thompson
Journal:  J Bacteriol       Date:  1989-04       Impact factor: 3.490

6.  Photochemical conversion of the O-intermediate to 9-cis-retinal-containing products in bacteriorhodopsin films.

Authors:  A Popp; M Wolperdinger; N Hampp; C Brüchle; D Oesterhelt
Journal:  Biophys J       Date:  1993-10       Impact factor: 4.033

7.  Expression of the archaebacterial bacterio-opsin gene with and without signal sequences in Escherichia coli: the expressed proteins are located in the membrane but bind retinal poorly.

Authors:  S Karnik; T Doi; R Molday; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Synthetic physiology strategies for adapting tools from nature for genetically targeted control of fast biological processes.

Authors:  Brian Y Chow; Amy S Chuong; Nathan C Klapoetke; Edward S Boyden
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

9.  Genetic cloning and functional expression in Escherichia coli of an archaerhodopsin gene from Halorubrum xinjiangense.

Authors:  Jie Feng; Hong-Can Liu; Jin-Fang Chu; Pei-Jin Zhou; Ji-An Tang; Shuang-Jiang Liu
Journal:  Extremophiles       Date:  2005-08-02       Impact factor: 2.395

10.  Effect of genetic modification of tyrosine-185 on the proton pump and the blue-to-purple transition in bacteriorhodopsin.

Authors:  D J Jang; M A el-Sayed; L J Stern; T Mogi; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.